![]() |
市场调查报告书
商品编码
1739420
全球液体处理系统市场规模(按类型、产品、最终用户、区域覆盖范围和预测)Global Liquid Handling Systems Market Size By Type, By Product, By End-User, By Geographic Scope And Forecast |
液体处理系统市场规模在 2024 年价值 39.9 亿美元,预计到 2032 年将达到 62 亿美元,2026 年至 2032 年的复合年增长率为 6.27%。
液体处理系统是用于在各种实验室和工业环境中精确分配、转移和分析液体的自动或半自动机器。这些系统融合了多种技术,包括移液器、分配器和机器人液体处理器,以提高液体管理程序的准确性和效率。液体处理系统通常用于实验室、药物开发、临床诊断和生物技术领域的样本製备、高通量筛检和试剂分配。
自动化、人工智慧和机器人技术的进步有望推动液体处理系统的发展。随着实验室不断寻求提高通量并减少人为错误,对先进液体处理技术的需求预计将持续成长。诸如整合即时监控软体、使用者友善介面以及与其他实验室设备通讯的改进等创新有望提高生产效率。个人化医疗和生物技术研究的持续关注,可能会增加对能够处理复杂流程和各种液体类型的多功能液体处理系统的需求。
预计到 2032 年底液体处理系统市场规模将达到 62 亿美元,复合年增长率为 6.27%。
影响全球液体处理系统市场的关键市场动态是:
关键市场驱动因素
製药和生物技术行业研发活动的增加:不断增长的研发支出推动了对液体处理系统的需求。根据美国国家科学基金会的数据,2018年美国研发总支出达到6,061亿美元,其中生命科学产业占了很大一部分。这种支出的成长需要现代化的液体处理技术,以确保准确且有效率的样品管理。
慢性病发生率上升,诊断检测需求增加:慢性病盛行率上升,导致诊断检测需求增加,进而推动液体处理系统市场发展。世界卫生组织 (WHO) 的数据显示,慢性病占全球死亡人数的 71%。美国疾病管制与预防中心 (CDC)的美国显示,美国每 10 人就有 6 人患有慢性病,这增加了诊断检测的需求,进而也推动了液体处理系统市场的发展。
个人化医疗日益受到重视:个人化医疗日益受到重视,为基因组学和蛋白质组学研究中的液体处理系统带来了新的视角。根据美国食品药物管理局(FDA) 的数据,近年来批准的新药中 25% 是个人化药物。预计这一趋势将持续下去,定製药物联盟 (Tailored Medicine Coalition) 预测,定製药物很快将占所有新药认证的 34%,这需要先进的液体处理设备来进行复杂的检测和样品处理。
主要挑战
维护和支援问题:液体处理系统需要定期维护和支援才能正常运作。如果不进行定期维护,设备将变得不稳定,从而增加停机时间并降低生产力。能否及时获得技术支援也可能是一个问题,尤其是对于可能没有专门维护人员的小型企业而言。
经济因素与预算限制:经济波动会影响各学科的研究经费和预算。资金不足可能导致机构推迟或减少对先进液体处理系统的投入,从而限制关键技术的取得。这种情况可能会对生命科学公司的研发、创新和整体发展产生负面影响。
整合复杂性:将液体处理系统与现有的实验室操作和设备整合可能颇具挑战性。确保与各种软体、仪器和方案的相容性可能相当困难。整合困难可能导致工作流程中断、培训要求更高以及潜在的研究延误,所有这些都会降低生产力。
主要趋势:
自动化和机器人技术:液体处理系统市场的一个突出趋势是自动化和机器人技术在实验室中的应用日益广泛。自动化液体处理系统可以提高实验通量,消除人为错误,并提高准确性。随着研究需求的增加,实验室正在寻求简化流程并提高效率,推动了对这些先进系统的需求。
客製化和模组化:为了满足各种研究应用的特定需求,液体处理系统正变得越来越可自订且灵活。客製化解决方案使实验室能够根据其独特的方案和工作流程客製化系统,从而提高效率和精度。这一趋势源于对实验设计灵活性和最高性能的需求。
高通量筛检需求日益增长:药物研发和基因组学领域高通量筛检应用的兴起,推动了改进液体处理系统的需求。这些系统能够快速处理大量样本,从而显着缩短研究时间。对更快、更有效率的筛检程序的需求,正在推动对液体处理系统的投资。
Liquid Handling Systems Market size was valued at USD 3.99 Billion in 2024 and is projected to reach USD 6.2 Billion by 2032, growing at a CAGR of 6.27% from 2026 to 2032.
Liquid handling systems are automated or semi-automatic machines used to precisely dispense, move, and analyze liquids in a variety of laboratory and industrial environments. These systems incorporate a variety of technologies, including pipettes, dispensers, and robotic liquid handlers, to improve the precision and efficiency of liquid management procedures. Liquid handling systems are commonly used in research labs, pharmaceutical development, clinical diagnostics, and biotechnology for sample preparation, high-throughput screening, and reagent dispensing.
Advancements in automation, artificial intelligence, and robotics appear to be driving liquid handling systems forward. As laboratories aim for more throughput and less human error, the demand for advanced liquid handling technologies is projected to rise. Productivity will be increased by innovations such as integrated real-time monitoring software, user-friendly interfaces, and improved communication with other laboratory instruments. The ongoing focus on personalized medicine and biotechnology research will increase the demand for versatile liquid handling systems that can handle complex processes and a wide range of liquid types.
Liquid Handling Systems Market is estimated to grow at a CAGR of 6.27% & reach US$ 6.2 Bn by the end of 2032
The key market dynamics that are shaping the global liquid handling systems market include:
Key Market Drivers:
Increasing R&D Activities in Pharmaceutical and Biotechnology Industries: The increase in R&D spending is boosting the demand for liquid handling systems. According to the National Science Foundation, total R&D spending in the United States hit USD 606.1 Billion in 2018, with the life sciences industry accounting for a considerable percentage. This increased expenditure demands modern liquid handling technologies to ensure precise and efficient sample management.
Increased Frequency of Chronic Diseases and Demand for Diagnostic Tests: The increased prevalence of chronic diseases increases the demand for diagnostic testing, which drives the liquid handling systems market. According to the World Health Organization, chronic diseases account for 71% of global mortality. According to the Centers for Disease Control and Prevention (CDC), 6 out of every 10 persons in the United States have a chronic disease, increasing demand for diagnostic tests and, as a result, liquid handling systems.
Increasing Focus on Personalized Medicine: The growing emphasis on customized medicine is offering new prospects for liquid handling systems in genomes and proteomics research. According to the US Food and Drug Administration (FDA), 25% of all new pharmaceuticals licensed in recent years have been personalized medicines. This trend is projected to continue, with the Tailored Medicine Coalition forecasting that tailored medicines will account for 34% of all new drug approvals soon, necessitating advanced liquid handling equipment for complex assays and sample processing.
Key Challenges:
Maintenance and Support Issues: In order to perform properly, liquid handling systems must be maintained and supported on a regular basis. Without regular maintenance, equipment can become less reliable, resulting in increased downtime and loss of productivity. The availability of timely technical help can also be an issue, especially for smaller firms that may lack dedicated maintenance staff.
Economic Factors and Budget Constraints: Economic fluctuations can have an impact on research funding and budgets across multiple sectors. When financing is short, organizations may postpone or reduce expenditures in advanced liquid handling systems, limiting access to critical technologies. This circumstance can have a negative impact on research development, innovation, and the general advancement of the life sciences firm.
Complexity of Integration: Integrating liquid handling systems with current laboratory operations and equipment can be difficult. It may be difficult to ensure compatibility with varied software, instruments, and protocols. Difficulties with integration can cause workflow disruptions, higher training requirements, and potential research delays, all of which reduce productivity.
Key Trends:
Automation and Robotics: The growing use of automation and robotic technologies in laboratories is a prominent trend in the liquid handling system market. Automated liquid handling systems increase experiment throughput, eliminate human error, and improve accuracy. As research demands rise, laboratories attempt to streamline procedures and increase efficiency, fueling the demand for these advanced systems.
Customization and Modularity: To address the specific needs of various research applications, liquid handling systems are becoming increasingly customizable and flexible. Customized solutions enable laboratories to adjust systems to unique protocols and workflows, thereby increasing efficiency and accuracy. This tendency is driven by the requirement for flexibility in experimental design as well as the demand for peak performance.
Increased Demand for High-Throughput Screening: The growth of high-throughput screening applications in drug development and genomics is driving up demand for improved liquid handling systems. These systems enable the quick processing of massive sample sets, resulting in much shorter research timetables. The demand for faster and more efficient screening procedures is driving investment in liquid handling systems.
Here is a more detailed regional analysis of the global liquid handling systems market:
North America:
The North American region is currently leading the global liquid handling systems market, owing to its strong pharmaceutical and biotechnology sectors, large research activities, and advanced healthcare infrastructure. According to the Pharmaceutical Research and Manufacturers of America, the U.S. biopharmaceutical industry would invest around USD 102.3 Billion in R&D in 2021, more than tripling its investment since 2010. This major investment highlights the need for better liquid handling technologies to help with medication research and development. The 17% growth in active Investigational New Drug (IND) applications between 2016 and 2020 indicates a growing number of clinical trials requiring precision liquid handling for sample preparation and analysis.
The focus on customized medicine and genetics research is driving market expansion. The COVID-19 pandemic has expedited the deployment of automated liquid handling systems in diagnostic laboratories, with over 1.1 billion COVID-19 tests performed in the United States as of October 2024, emphasizing the importance of efficient liquid handling processes. Moving forward, the North American liquid handling systems market is likely to expand as advances in life sciences research, increasing laboratory automation, and the rising need for high-throughput screening drive investment and innovation.
Asia Pacific:
The Asia Pacific region is experiencing rapid growth in the global liquid handling systems market, owing to significant investments in healthcare infrastructure, robust R&D activities, and the rapid expansion of pharmaceutical and biotechnology sectors in countries such as China, India, and Japan. India's domestic pharmaceutical market is estimated to reach USD 65 Billion by 2024, while Japan's biotechnology sector is projected to increase from USD 40 Billion in 2020 to USD 120 Billion by 2032. The growing emphasis on precision medicine and genomics research, as evidenced by China's USD 9.2 Billion investment effort, raises the demand for innovative liquid handling systems.
The COVID-19 pandemic has spurred the implementation of automated liquid handling equipment in diagnostic laboratories, with over 370 million COVID-19 tests performed in the Western Pacific region by October 2024, according to the World Health Organization. Demand for liquid handling technology is also being driven by the region's rise of Contract Research Organizations (CROs), which is predicted to expand at a CAGR of 9.8% between 2020 and 2027. Looking ahead, the Asia Pacific liquid handling systems market is expected to grow to USD 5.2 Billion by 2025, driven by increased funding for life sciences research, increased R&D spending in pharmaceuticals and biotechnology, and a growing awareness of the efficiency and accuracy benefits of automated liquid handling solutions.
The Global Liquid Handling Systems Market is Segmented on the basis of Type, Product, End-User, And Geography.
Based on Type, the market is bifurcated into Manual Liquid Handling, Electronic Liquid Handling, Automated Liquid Handling, and Semi-automated Liquid Handling. The fastest-growing segment is automated liquid handling, which is being driven by an increase in laboratory demand for efficiency, precision, and high throughput. This market benefits from advances in robotics and automation technology, which simplify complex liquid handling operations and reduce human error. Manual liquid handling remains a dominant segment due to its broad use in many laboratory settings, especially in resource-limited locations and smaller laboratories where automation may not be possible.
Based on Product, the market is segmented into Automated Workstations, Pipettes, Dispensers, and Burettes. Pipettes are the most popular section due to their long history and critical significance in laboratories for precise liquid measurement and transfer. They are widely used in a variety of purposes, including academic research and clinical diagnostics, making them a laboratory standard. Automated workstations are the fastest-growing market, owing to technological developments and an increased demand for efficiency and precision in high-throughput conditions. These automated systems increase efficiency by integrating numerous liquid handling processes, eliminating human interaction and errors, and making them appealing to laboratories looking to streamline operations.
Based on End-User, the market is segmented into Pharmaceutical and Biotechnology Industry, Contract Research Organization, and Academic Institutes. The pharmaceutical and biotechnology industries dominate the market, owing to their reliance on precise liquid handling for drug discovery, development, and testing. The industry's enormous investments in R&D fuel demand for improved liquid handling technologies. Contract research organizations (CROs) are the fastest-growing segment, as they increasingly use advanced liquid handling technologies to improve the efficiency and accuracy of their research services. The increasing number of clinical trials and pharmaceutical corporations' outsourcing of research activities has fueled CRO growth.
The "Global Liquid Handling Systems Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Agilent Technologies, Bio-Rad Laboratories, Inc., Corning Incorporated, Eppendorf AG, Hamilton Company, PerkinElmer, Inc., Promega Corporation, Thermo Fisher Scientific, Inc., Danaher Corporation, Tecan Trading AG, and 10x Genomics. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.